Search News:

'Pharma News'


USFDA drug approval for Claris Lifesciences
Ahmedabad-based Claris Lifesciences Ltd, a parenteral drug company has received drug approval from US drug authorities for hypertension and angina treatment injection. While another city-based drug maker.

Claris Lifesciences announced that it has received an Abbreviated New Drug Application (ANDA) approval for Metroprolol Tartrate injection in the United States of America (US). The injection is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used for treatment or prevention of heart attack.

As per American Heart Association an estimated 1.4 million people annually will suffer a heart attack or AMI, says Claris press statement. It further says that as per IMS data in 2009 sales of Metroprolol as approximately $13 million. Currently, Claris has 10 ANDAs approved in its name across six molecules and has a total filing of 32 ANDAs across 21 molecules.





Latest Issue
Online Magazine